Insights

Cell Therapy

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Cell Therapy

Clear filter

Navigating the Cost and Time of Cell Therapy Manufacturing Process Automation

In this article, we discuss available devices and technology developments for cell therapy products in preclinical, clinical and early commercialization phases.

Avoiding the Potholes Along the Pathway to Commercial Cell Therapies

Panelists from Cell Therapies, Duke University and Fate Therapeutics discuss how they envision the road ahead for some of the biggest challenges in cell therapy manufacturing.

What’s Next for Commercial Cell Therapy Manufacturing?

Now it's getting serious. Panelists from bluebird bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the coming era of industrialized cell therapy production.

Ensuring Bioprocess Flexibility for Cell Therapy Production

Choosing cell therapy production equipment that is suitable for the current stage of development and will also enable smooth transfer to commercial manufacture.

The Human Side of Stem Cell Therapies

Reporting from ISSCR 2018, the world's largest stem cell-focused meeting, Invetech scientist Alan Ching is reminded of the importance of this industry.

Would You Pay $12 for a Loaf of Bread?

Invetech's Geoff Ball highlights dominant themes from a recent Phacilitate automation webinar on challenges of automation as the cell therapy industry matures.

Manufacturing and cGMP for Cell and Gene Therapies

Action-oriented solutions for establishing cGMP manufacture of cell and gene therapies as companies progress their development programs towards commercialization.

Infographic: Maximizing ROI in Cell Therapy Production

A visual representation highlighting challenges in cell therapy manufacturing, the benefits of automating an open process, and when to invest to maximize ROI.

WHITE PAPER: Commercializing Cell and Gene Therapies

In this white paper, market-leading experts from AmerisourceBergen, TrakCel and Invetech discuss what it takes to design and execute an effective commercialization strategy.

Achieving Cost Effective Cell Therapies with Automation

Automation is a key element in enabling a cost-effective therapy to be manufactured, but how should companies determine what to invest in and when?

Meeting the Cell Therapy Cost Challenge with Automation

Peter Olagunju (bluebird bio), Rodney Rietze (Novartis) and Dieter Hauwaerts (Celyad) discuss how to achieve cost-effective therapies through automation.

INTERVIEW SERIES: Strategies for Success in Cell & Advanced Therapies

Read interviews with cell therapy industry leaders for their perspectives on obtaining funding, regulatory considerations and scaling manufacturing